52
Amani Therapeutics, Inc. raises $31.1M under Reg D
Company raise · Closed · Offering $31.1M · Sold $31.1M · NEW YORK, NY · filed 2025-12-10
55
Amani Therapeutics raises $60M in Delaware health care offering
Company raise · Raising · NEW YORK, NY · Form D filed 2026-10-01
Amani Therapeutics, a Delaware corporation incorporated in 2025, is raising $60M under Regulation D exemption 6(b). The company has sold $35M to 5 investors so far and is seeking an additional $25M.
$50M+ raiseoperating_company
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| Alice Lee | Executive Officer |
| -- RTW Holdings VI, LLC | Promoter |
| Robert Swoboda | Executive Officer |
| Lauren Cuje | Director |
| Peter Fong | Director |
| Connor Williams | Director |
Signed by Robert Swoboda, Chief Operating Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.